Women's Health
What Is a Normal DHEA-S Level in Menopause?
DHEA-S is one of the most overlooked markers on a menopause hormone panel — yet it drops by as much as 80% between your 20s and your 70s. Understanding what counts as a normal level, and what a low result actually means for energy, libido, bone density, and mood, can change the conversation you have with your doctor.

What Is a Normal DHEA-S Level in Menopause?
For most menopausal women, a DHEA-S level between 35 and 200 µg/dL is considered within the broad reference range — but "normal" shifts significantly with age, and the number alone doesn't tell the whole story. The main caveat: labs use population-derived ranges, not optimal ranges, so a result technically inside the reference window can still be functionally low. Women with severe fatigue, libido changes, or mood disruption often find their DHEA-S sitting at the low end of "normal."
---
Why DHEA-S Matters More in Menopause Than Most Doctors Mention
Dehydroepiandrosterone sulfate (DHEA-S) is the sulfated, storage form of DHEA — the most abundant steroid hormone in the human body. Secreted primarily by the adrenal cortex, it serves as a precursor to both estrogens and androgens. When ovarian estrogen production collapses at menopause, peripheral conversion of DHEA into estrone and testosterone becomes a more significant contributor to hormonal balance than most clinicians acknowledge (Labrie et al., Journal of Steroid Biochemistry and Molecular Biology 2003; PMID: 12732302).
Because DHEA production peaks in your mid-20s and declines roughly 2–3% per year thereafter — a process called adrenopause — menopausal women are simultaneously dealing with both ovarian shutdown and adrenal decline. The compounding effect can be significant. By the time a woman reaches her late 50s or early 60s, DHEA-S levels may be 70–80% lower than they were at her peak (Orentreich et al., Journal of Clinical Endocrinology & Metabolism 1984; PMID: 6480608).
This decline is associated with a cluster of symptoms that overlap closely with menopause itself — which is part of why DHEA-S is so frequently under-evaluated on standard hormone panels. When everything looks like menopause, it's easy to miss the adrenal contribution.
---
Reference Ranges for DHEA-S by Age in Women
Lab reference ranges vary slightly between laboratories, but the following table reflects commonly cited values across major clinical labs and published endocrinology guidelines:
| Age Range | DHEA-S Reference Range (µg/dL) | Notes |
|---|---|---|
| 20–29 | 65–380 | Peak production decade |
| 30–39 | 45–270 | Gradual decline begins |
| 40–49 | 32–240 | Perimenopausal transition |
| 50–59 | 26–200 | Post-menopause, wider variance |
| 60–69 | 13–130 | Adrenopause well established |
| 70+ | 10–90 | Low end expected; symptom context matters |
Important: a result of 35 µg/dL in a 55-year-old technically falls "in range" — but it sits at the very bottom of that window. Clinical endocrinologists increasingly distinguish between within-range and functionally adequate, particularly when symptoms are present.
If you're also tracking other hormones during this transition, understanding what a normal estradiol level looks like in menopause helps contextualize where DHEA-S fits in the broader hormonal picture.
---
What Low DHEA-S Feels Like — and Why It's Often Dismissed
Low DHEA-S doesn't announce itself with a single dramatic symptom. Instead, it presents as a constellation of vague, overlapping complaints that are extremely easy to attribute to "just menopause" or "just aging":
- Persistent fatigue that doesn't improve with sleep
- Reduced libido and vaginal dryness (beyond typical estrogen-related changes)
- Muscle weakness and slower recovery from exercise
- Mood changes, particularly low motivation and mild depression
- Brain fog and difficulty concentrating
- Reduced bone mineral density
A 2006 prospective study found that lower DHEA-S levels in postmenopausal women were associated with significantly worse physical function and increased frailty markers — independent of estrogen status (Valenti et al., Journal of the American Geriatrics Society 2009; PMID: 19682126).
The frustration many women experience is real and documented. Getting dismissed when symptoms are diffuse and labs appear "normal" is a systemic problem in how menopause care is delivered. If you suspect your thyroid might also be contributing to fatigue and mood changes, checking what a normal thyroid level looks like in menopause is a logical next step alongside your DHEA-S result.
---
What Causes DHEA-S to Drop Faster Than Expected?
Age-related adrenopause is inevitable, but several factors can accelerate the decline or push levels below the already-lowered menopausal baseline:
Chronic psychological stress is one of the most significant accelerants. Sustained cortisol elevation — the hallmark of chronic stress — competes with DHEA production in the adrenal glands via a process sometimes called the "pregnenolone steal." The more adrenal resources are diverted to cortisol synthesis, the less is available for DHEA. This is why women who describe stress as a trigger for symptom flares are often onto something physiologically real: elevated cortisol suppresses the DHEA/cortisol ratio, and that ratio is increasingly viewed as a meaningful marker of adrenal resilience (Lennartsson et al., Stress 2013; PMID: 23301770).
Other accelerating factors include:
- Prolonged glucocorticoid (steroid) medication use
- Adrenal insufficiency or subclinical adrenal dysfunction
- Chronic illness or autoimmune conditions
- Very low caloric intake or disordered eating history
- Sedentary lifestyle (regular resistance training is associated with higher DHEA-S in older adults)
- Elevated insulin and metabolic dysfunction
If fasting insulin is elevated, it may be directly suppressing adrenal androgen output. Understanding what causes fasting insulin to be out of range can help identify whether metabolic factors are compounding the hormonal picture.
---
The DHEA-S and Cortisol Ratio: What It Tells You About Adrenal Health
Looking at DHEA-S in isolation only tells part of the story. Clinicians who specialize in functional and integrative medicine often assess the DHEA-S to cortisol ratio — either from serum or saliva measurements — to evaluate adrenal output as a whole system.
A healthy ratio reflects adequate production of both hormones in roughly appropriate balance. As women age and DHEA-S falls while cortisol may remain elevated (particularly with chronic stress), the ratio skews unfavorably. Low DHEA-S paired with persistently high cortisol is associated with accelerated immune aging, worse cardiovascular risk profiles, and reduced cognitive resilience in postmenopausal populations (Heaney et al., Journal of Endocrinology 2012; PMID: 22389449).
This is the mechanism that connects stress-related symptom flares to measurable hormonal changes — it isn't purely psychological. The adrenal glands are genuinely being pulled in two directions simultaneously.
---
Should You Supplement with DHEA?
Over-the-counter DHEA supplements are widely available in the US (unlike in many other countries, where they require a prescription), which creates a DIY-supplementation temptation. The clinical picture here is nuanced.
Evidence for DHEA supplementation in menopause includes:
- Improvements in sexual function, particularly in women with adrenal insufficiency (Baulieu et al., PNAS 2000; PMID: 10716732)
- Modest improvements in bone mineral density at the lumbar spine in some trials
- Improvements in mood and wellbeing scores in double-blind studies of women with low baseline levels
Caveats that matter:
- Typical OTC doses (25–50mg/day) may be pharmacologically higher than physiological replacement
- DHEA converts peripherally to androgens and estrogens — in women with hormone-sensitive conditions, this matters
- Response varies widely based on baseline levels and individual conversion enzymes
- Acne, oily skin, and unwanted hair growth are documented side effects at higher doses
The clinical consensus is that DHEA supplementation is most appropriate for women with confirmed low levels, not as a general anti-aging supplement. Testing before supplementing is not optional — it's essential.
For context on how other hormonal markers interact during this transition, reviewing what a normal testosterone level looks like in menopause is useful, since DHEA directly influences androgen conversion.
---
How DHEA-S Connects to Bone Health, Heart Health, and Cognition
The downstream effects of chronically low DHEA-S extend well beyond libido and fatigue. Three body systems deserve particular attention:
Bone density: DHEA-S contributes to bone protection both directly (androgen receptors in osteoblasts) and indirectly through peripheral conversion to estrogen. Prospective data from the Study of Osteoporotic Fractures showed that lower DHEA-S in older women was independently associated with increased fracture risk.
Cardiovascular health: DHEA has been shown in several observational studies to be inversely associated with cardiovascular disease risk in women. While causality hasn't been firmly established in intervention trials, the correlation is consistent across epidemiological data.
Cognitive function: A 2014 review in Frontiers in Aging Neuroscience noted that DHEA and DHEA-S levels correlate with cognitive performance in aging populations, with low levels associated with greater risk of cognitive decline — though supplementation trials show inconsistent results, likely due to heterogeneity in baseline levels.
If you're also monitoring what a normal cholesterol level looks like in menopause, know that DHEA-S interacts with lipid metabolism — another reason a comprehensive panel matters more than any single biomarker.
---
What This Means for Your Formula
Ones doesn't stock exogenous DHEA as a stand-alone active — and that's appropriate, because DHEA supplementation genuinely requires lab confirmation and clinical oversight before it's warranted. What Ones does address is the upstream adrenal environment that governs how much DHEA your body produces and maintains.
Adrenal Support (Ones proprietary System Blend): This blend is designed to support the adrenal stress response system — the same system that, when chronically taxed by elevated cortisol output, suppresses DHEA-S production. Supporting adrenal resilience is a physiologically logical strategy for women whose low DHEA-S is driven by chronic HPA-axis overactivation rather than pure age-related adrenopause.
Ashwagandha KSM-66 at 600mg: This is the clinically validated dose used in double-blind trials demonstrating significant reductions in serum cortisol. Lower cortisol burden on the adrenal glands theoretically creates more physiological space for DHEA synthesis. A 60-day randomized controlled trial found KSM-66 reduced cortisol by 27.9% compared to placebo while improving stress and anxiety scores (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). In a Ones formula, this ingredient is dosed at exactly this clinical threshold — not at the 200–300mg doses commonly seen in generic supplements.
Rhodiola Rosea: As an adaptogen with evidence for modulating the HPA axis, Rhodiola is a complementary ingredient for women whose DHEA-S suppression is stress-driven. It's included in Ones formulas where AI analysis of cortisol burden, stress history, and wearable recovery data indicates adrenal-related fatigue patterns.
Ones uses bloodwork and wearable data together to identify whether low DHEA-S appears driven by adrenal stress load versus age-related adrenopause — and calibrates the formula accordingly. The difference matters for which ingredients are prioritized.
---
Key Takeaways
- Normal DHEA-S in menopause generally falls between 35 and 200 µg/dL, but "in-range" doesn't always mean functionally adequate — symptom context matters as much as the number.
- DHEA-S declines 70–80% from peak levels by the late postmenopausal years, driven by both adrenopause and compounding factors like chronic stress and metabolic dysfunction.
- Chronic stress accelerates DHEA-S decline by diverting adrenal pregnenolone toward cortisol synthesis — this is a physiologically documented mechanism, not a vague wellness claim.
- DHEA supplementation is an option for confirmed-low cases, but peripheral conversion to estrogen and androgens means it requires lab confirmation and clinical supervision, not DIY self-prescription.
- The DHEA-S to cortisol ratio is a more informative picture of adrenal health than DHEA-S alone — ask your provider about assessing both.
- Upstream adrenal support — through adaptogens like KSM-66 ashwagandha at clinical doses — offers a physiologically rational approach for women whose low DHEA-S appears driven by chronic HPA-axis stress rather than pure age-related decline.
---
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting or stopping any hormone-related supplementation.